The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors

• Main Authors: Suying Lu (Author), Ye Hong (Author), Huimou Chen (Author), Liuhong Wu (Author), Feifei Sun (Author), Juan Wang (Author), Jia Zhu (Author), Yi Que (Author), Lian Zhang (Author), Zijun Zhen (Author), Xiaofei Sun (Author), Junting Huang (Author), Yizhuo Zhang (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: Refractory or recurrent pediatric solid tumors lack effective treatments, and are associated with dismal outcomes. Hence, there is an urgent need for a novel therapeutic strategy. This study aimed to evaluate the efficacy and safety of anlotinib, a novel oral multi-kinase angiogenesis inh...